Aimee  Wilkin  to  Reverse Transcriptase Inhibitors
                            
                            
                                This is a "connection" page, showing publications  Aimee  Wilkin  has written about  Reverse Transcriptase Inhibitors.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.130
         
        
        
     
 
    
        
        - 
            Floris-Moore MA, Mollan K, Wilkin AM, Johnson MA, Kashuba AD, Wohl DA, Patterson KB, Francis O, Kronk C, Eron JJ. Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results. Antivir Ther. 2016; 21(1):55-64.
            
            
                Score: 0.130